期刊文献+

胰岛素样生长因子2基因印迹状态及其启动子活性在巨大儿胎盘组织中的变化 被引量:2

Insulinllike growth factor 2 imprinting status and promoter usage in the placenta of macrosomia
原文传递
导出
摘要 目的通过检测巨大儿的胎盘组织中胰岛素样生长因子2(IGF_2)基因印迹状态及其mRNA 表达水平和不同启动子活性,探讨巨大儿的发生机理。方法根据 IGF_2基因第9外显子Apa Ⅰ酶切位点多态性,应用 RT-PCR 结合限制性片段长度多态性技术,对83例分娩巨大儿产妇的胎盘组织(巨大儿组)和同期分娩正常体重儿的85例产妇的胎盘组织(正常体重儿组)进行杂合子筛选,对筛选出的杂合子进行 IGF_2基因印迹状态分析,用 RT-PCR 半定量检测两组胎盘组织 IGF_2mRNA 表达水平及不同启动子的活性。结果两组胎盘组织中各有30例杂合子。在这些杂合子中,IGF_2基因均为单等位基因表达,呈维持印迹状态。巨大儿组胎盘组织中 IGF_2 mRNA 表达水平为2.2±1.2,明显高于正常体重儿组的1.6±0.6,两组比较,差异有统计学意义(P<0.05);IGF_2 4个启动子(P1、P2、P3、P4)在两组胎盘组织中均表现为:P4活性最强,P3次之,P2较弱,P1最弱,仅在两例(巨大儿组和正常体重儿组各1例)中检测到 P1起始的转录本;两组胎盘组织 IGF_2不同启动子活性检测分别为:正常体重儿组P2:0.19±0.17、P3:0.98±0.80、P4:2.05±1.27;巨大儿组P2:0.20±0.20、P3:0.99±0.72、P4:2.06±1.26,两组分别比较,差异均无统计学意义(P>0.05)。结论胎盘组织中 IGF_2 mRNA 表达水平的增加可能与巨大儿的形成有关,而 IGF_2基因印迹状态和启动子活性与巨大儿的形成无明显关系。 Objective To study the mechanism of marcosomia by investigating insulin-like growth factor 2 ( IGF2 ) imprinting status, expression level and the promoter usage in the placenta of macrosomia, Methods We selected heterozygous cases for Apa Ⅰ polymorphism in exon 9 of IGF2 gene and then analyzed its imprinting status in 168 placentas of macrosomia and normal pregnancies. IGF2 transcription levels and promoter usages in macrosomic and normal placenta were evaluated by using semi-quantitative RT-PCR assay. Results Thirty specimens of maerosomic placenta and 30 of normal placenta were identified as heterozygnus for IGF2. All of the heterozygous specimens showed maintenance of imprinting. The expression of placental IGF2 mRNA(2.2 ± 1.2)was significantly higher in macrosomia than that of normal weight group (1.6 ± 0. 6 ,P 〈 0. 05 ). Of four promoters, P4 was the most powerful, P3 was the second, and P2 was weakest. Transcripts from P1 were the fewest, and they were only detected in two specimens. The value of P4 was 2.06 ± 1.26, P3 0. 99 ± 0. 72, P2 0. 20 ± 0. 20 in macrosomia group and P4 2.05 ± 1.27, P3 0. 98 ±0. 80, P2 0. 19±0. 17 in normal group. There were no significant differences between two groups (P 〉 0. 05 ). Conclusion It is possible that over expression of IGF2 in placenta contributes to macrosomia while the promoter usage and imprinting status are not associated with maerosomia.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2007年第5期309-314,共6页 Chinese Journal of Obstetrics and Gynecology
基金 江苏省自然科学基金(BK2004008) 江苏省科技发展计划(国际科技合作)(BZ2004008)
关键词 巨大胎儿 胎盘 胰岛素样生长因子Ⅱ 基因组印迹 启动区 Fetal macrosomia Placenta Insulin-like growth factor Ⅱ Genomic imprinting Promoter regions (genetics)
  • 相关文献

参考文献19

  • 1Silva D, Venihaki M, Guo WH, et al. IGF2 deficiency results in delayed lung development at the end of gestation. Endocrinology, 2006, 147: 5584-5591.
  • 2Reik W, Constaneia M, Dean W, et al. IGF2 imprinting in development and disease. Int J Dev Biol, 2000, 44: 145-150.
  • 3Vu TH, Hoffman AR. Promoter-specific imprinting of the human insulin-like growth factor-Ⅱ gene. Nature, 1994, 371: 714-717.
  • 4Constoncia M, Hemberger M, Hughes J, et al. Placental-specific IGF-Ⅱ is a major modulator of placental and fetal growth. Nature, 2002, 417: 945-948.
  • 5戴毅敏,胡娅莉,王志群,李洁.汉族新生儿脐血中IGF2印迹表达状态的调查[J].中华医学遗传学杂志,2007,24(1):10-14. 被引量:1
  • 6Chen CL, Ip SM, Cheng D, et aL Loss of imprinting of the IGF- Ⅱ and H19 genes in epithelial ovarian cancer. Clin Cancer Res, 2000, 6 : 474-479.
  • 7Hack M, Flannery DJ, Scbluchter M, et al. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med, 2002, 346 : 149-157.
  • 8Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res, 1997, 48: 11-16.
  • 9Reik W, Constancia M, Fowden A, et al. Regulation of supply and demand for mutermal nutrients in mammals by imprinting genes. J Physiol, 2003, 547: 35-44.
  • 10Dechiaca TM, Robertson E J, Efstratiadis A, et al. Parental imprinting of the mouse insulin-like growth factor- Ⅱ gene. Cell, 1991, 64: 849-859.

二级参考文献20

  • 1Sun FL,Dean WL,Kelsey G,et al.Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.Nature,1997,389:809-815.
  • 2Eggenschwiler J,Ludwig T,Fisher P,et al.Mouse mutant embryos overexpressing IGF-Ⅱ exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes.Genes Dev,1997,11:3128-3142.
  • 3Sakatani T,Kaneda A,Iacobuzio-Donahue CA,et al.Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice.Science,2005,307:1976-1978.
  • 4Cui H,Horon IL,Ohlsson R,et al.Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.Nat Med,1998,4:1276-1280.
  • 5Vorwerk P,Wex H,Bessert C,et al.Loss of imprinting of IGFⅡ gene in children with acute lymphoblastic leukemia.Leuk Res,2003,27:807-812.
  • 6Fukuzawa R,Breslow NE,Morison IM,et al.Epigenetic differences between Wilms' tumours in white and east-Asian children.Lancet,2004,363:446-451.
  • 7Joyce JA,Lam WK,Catchpoole DJ,et al.Imprinting of IGF2 andH19:lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.Hum Mol Genet,1997,6:1543-1548.
  • 8Woodson K,Flood A,Green L,et al.Loss of insulin-like growth factorⅡ imprinting and the presence of screen-detected colorectal adenomas in women.J Natl Cancer Inst,2004,96:407-410.
  • 9Morison IM,Eccles MR,Reeve AE.Imprinting of insulin-like growth factor 2 is modulated during hematopoiesis.Blood,2000,96:3023-3028.
  • 10Ong KK,Dunger DB.Birth weight,infant growth and insulin resistance.Eur J Endocrinol,2004,151(Suppl 3):131-139.

同被引文献24

  • 1周建军,胡娅莉.IGF系统对巨大儿形成的作用机制研究进展[J].国外医学(妇幼保健分册),2005,16(5):279-282. 被引量:4
  • 2梁梅英,陈梦捷,孙蓬明,魏丽惠.IGF-Ⅱ在足月妊娠胎盘中的表达及与胎儿出生体重关系的探讨[J].中国妇产科临床杂志,2007,8(3):210-212. 被引量:1
  • 3Zhang X, Decker A, Platt RW, et al. How big is too big?The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol, 2008, 198: 517. e1-517, e6.
  • 4Sferruzzi - Perri AN, Owens JA, Pringle KG, et al. The neglected role of insulin- like growth factors in the maternal circulation regulating fetal growth. Physio, 2011, 589: 7-20.
  • 5Lindsay RS, Westgate JA, Beattie J, et al. Inverse changes in fetal insulin- like growth factor (IGF) - 1 and IGF binding protein- 1 in association with higher birth weight in maternal diabetes. Clin Endoerinol (Oxf), 2007, 66:P322 - 328.
  • 6Esad K, Selim K, Mustafa A, et al. Serum insulin- like growth factor- I (IGF- I) IGF binding protein - a (IGFBP- 3) and leptin levels are related to abdominal aorticintimamedia thickness in macrosomic newborns. Growth Hormone IGFResearch, 2007, 17: 26-32.
  • 7Wiznitzer A, Reece EA, Homko C, et al. Insulin- like growth factors, their binding proteins, and fetal macrosomia in offspring of nondiabetic pregnant women. Am J Perinatol, 1998, 15: 23-28.
  • 8Forbes K, Souquet B, Garside R, et al. Transforming growth factor- {beta} (TGF {beta}) receptors Ⅰ/Ⅱ differentially regulate TGF {beta} 1 and IGF - binding protein - 3 mitogenie effects in the human placenta. Endocrinology, 2010, 151: 1723-1731.
  • 9Randhawa RS. The insulin like growth factor system and fetal growth restrictionn. Pediatr Endocrinol Rev, 2008, 6: 235 - 240.
  • 10Hua Jiang, Pengcheng Xun, Guanghua Luo, et al. Levels of insulin- like growth factors and their receptors in placenta in relation to maerosomia. Asia Pac J Clin Nutr, 2009, 18: 171 - 178.

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部